Related Experiment Videos
Tardive dyskinesia successfully treated with alprazolam
1Department of Psychiatry and Behavioral Sciences, Meharry Medical College, Nashville, Tennessee 37208.
Journal of the National Medical Association
|September 1, 1990
Summary
Tardive dyskinesia, a movement disorder from antipsychotic drugs, affects 15-20% of patients. This case study shows successful treatment of tardive dyskinesia using alprazolam, offering a potential new therapeutic option.
Area of Science:
- Neurology
- Pharmacology
Background:
- Tardive dyskinesia (TD) is a neurological disorder resulting from prolonged antipsychotic medication use.
- It affects 15-20% of patients, causing involuntary movements, muscle rigidity, and tic-like reactions.
- The underlying mechanism is believed to involve dopamine receptor hypersensitivity due to chronic dopamine blockade.